Publications by authors named "T Seufferlein"

Claim this Profile
T
Toward a new standard: Sequential multi-agent neoadjuvant chemotherapy in resectable pancreatic cancer.
Artur Rebelo, Thomas Seufferlein, Jorg Kleeff

Cancer Cell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD44 upregulation in chronic liver disease marks the transition to hepatocellular carcinoma and portends poor prognosis.
Rui Dong, Akshaya Srikanth, Umesh Tharehalli, Thomas Seufferlein, Reinhold Schirmbeck

Br J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide-based inhibition of CD44v6 renders liver carcinomas more susceptible to therapeutic intervention.
Akshaya Srikanth, Ranjitha Vishnu Anand Rao, Rui Dong, Umesh Tharehalli, Thomas F E Barth, Thomas Seufferlein

J Mol Med (Berl)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crew resource management and threat and error management improve team communication in endoscopy: a prospective study.
Dominik Schweikart, Anna Melzer, Niklas Sturm, Benjamin Mayer, Martin Müller, Thomas Seufferlein

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated, Cross-Entity Information on Preventive Measures for Bowel, Breast, and Prostate Cancer: Evaluation Study of the Web Application "Prevent-Take-Up".
Angelika M R Kestler, Julian D Schwab, Tanja Jähnig, Michael Karl Melzer, Friedemann Zengerling, Thomas Seufferlein

JMIR Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis